BCAX - Company ID 0002023658
The table below shows Bicara Therapeutics Inc.'s balance sheet line items across its last 2 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Cash & equivalents | $96.69M | $489.71M |
| Short-term investments | $318.12M | - |
| Receivables | - | - |
| Inventory | - | - |
| Total current assets | $422.05M | $502.53M |
| Property, plant & equipment | $330.00K | $155.00K |
| Goodwill | - | - |
| Total assets | $430.99M | $510.00M |
| Accounts payable | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current liabilities |
| $28.95M |
| $17.99M |
| Long-term debt | - | - |
| Total liabilities | $29.54M | $18.12M |
| Retained earnings | -$358.97M | -$221.02M |
| Total equity | $401.45M | $491.88M |